financial post
FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option
Financial Post • 1 MONTH AGO
Feds to invest millions in startup accelerator to boost Canadian defence and dual-use companies
Financial Post • 1 MONTH AGO
Topcon Agriculture Announces Expansion of Precision Ag Solved Territory into Western Canada
Financial Post • 1 MONTH AGO
Rally at Doug Ford’s office: Health care workers to protest on Monday morning as staffing cuts take toll on workers, patients
Financial Post • 1 MONTH AGO
Angeleno Group Announces Investment in NESTEC — A Leading Industrial Air Pollution Control Platform
Financial Post • 1 MONTH AGO